BCL10 anticorps

N° du produit ABIN7307562

Cet anticorps anti-BCL10 Polyclonal Lapin (ABIN7307562) détecte spécifiquement BCL10 dans WB, IF et IC. L’anticorps est réactif avec des échantillons de Humain, Souris et Rat.

Aperçu rapide pour BCL10 anticorps (ABIN7307562)

Antigène: BCL10 (B-Cell CLL/lymphoma 10 (BCL10))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL10 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunochromatography (IC)

Détail du produit anti-BCL10 anticorps

Fonction: Rabbit polyclonal antibody to BCL10

Specificité: Recognizes endogenous levels of BCL10 protein.

Attributs du produit: Rabbit polyclonal antibody to BCL10

Purification: The antibody was purified by immunogen affinity chromatography.

Immunogène: Recombinant full length protein of human BCL10

Information d'application

Indications d'application: WB (1:500 - 1:2000), IF/IC (1:50 - 1:200)

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

Date de péremption: 12 months

Détails sur BCL10

Antigène: BCL10 (B-Cell CLL/lymphoma 10 (BCL10))

Autre désignation: BCL10

Sujet: CIPER, CLAP, B-cell lymphoma/leukemia 10, B-cell CLL/lymphoma 10, Bcl-10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, hCLAP, CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER, Cellular homolog of vCARMEN, cCARMEN, Cellular-E10, c-E10, Mammalian CARD-containing adapter molecule E10, mE10

ID gène: 8915, 12042, 83477

UniProt: O95999, Q9Z0H7, Q9QYN5

Pathways: TCR Signaling, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteins